Edesa Biotech Total Current Liabilities

Edesa Biotech (EDSA) currently reports a total current liabilities of $2.2M as of March 2026. That compares with $910K in the prior-year period — up 139.2% year over year. Use the charts on this page to explore Edesa Biotech's total current liabilities history and peer comparisons.

Edesa Biotech's total current liabilities increased from $910K to $2.2M — a 139.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Edesa Biotech reported $2.2M in total current liabilities as of March 2026. That compares with $910K in the prior-year period — up 139.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $2.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Edesa Biotech, and consider following EDSA for alerts when major investors trade the stock.

Edesa Biotech is classified in the Healthcare sector. On total current liabilities, it currently shows $2.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EDSA with unrelated industries.